ID Biomedical - Common Shares (MM) (IDBE) 銘柄情報

ID Biomedical announces closing of acquisition by GlaxoSmithKline

VANCOUVER, Dec. 8 /PRNewswire-FirstCall/ -- ID Biomedical Corporation (TSX: IDB; NASDAQ: IDBE) ("ID Biomedical") announced that the acquisition of ID Biomedical by GlaxoSmithKline plc and...

ID Biomedical announces receipt of court approval for acquisition by GlaxoSmithKline

VANCOUVER, Dec. 6 /PRNewswire-FirstCall/ -- ID Biomedical Corporation (TSX: IDB; NASDAQ: IDBE) ("ID Biomedical") announced that today the British Columbia Supreme Court has approved the proposed...

ID Biomedical provides update on application for court approval of acquisition by GlaxoSmithKline

VANCOUVER, Dec. 5 /PRNewswire-FirstCall/ -- ID Biomedical Corporation (TSX: IDB; NASDAQ: IDBE) ("ID Biomedical") announced today that it has applied to the British Columbia Supreme Court for...

ID Biomedical announces rescheduling of court hearing to approve acquisition by GlaxoSmithKline

VANCOUVER, Nov. 18 /PRNewswire-FirstCall/ -- ID Biomedical Corporation (TSX: IDB; NASDAQ: IDBE) ("ID Biomedical") announced today that its application to the British Columbia Supreme Court to...

ID Biomedical announces results of securityholders' votes relating to acquisition by GlaxoSmithKline

VANCOUVER, Nov. 16 /PRNewswire-FirstCall/ -- ID Biomedical Corporation (TSX: IDB; NASDAQ: IDBE) ("ID Biomedical") announced that today its securityholders have voted to approve the proposed...

ID Biomedical reports 2005 third quarter results

ID Biomedical Provides Update on Vaccine Development Programs

- Clinical testing of FluINsure in children has begun - Clinical testing of StreptAvax to be postponed VANCOUVER, Oct. 24 /PRNewswire-FirstCall/ -- ID Biomedical Corporation (TSX: IDB; NASDAQ:...

ID Biomedical announces mailing of meeting materials

VANCOUVER, Oct. 20 /PRNewswire-FirstCall/ -- ID Biomedical Corporation (TSX: IDB; NASDAQ: IDBE) ("ID Biomedical") announced that today it has mailed to security holders a notice of meeting...

GlaxoSmithKline To Acquire ID Biomedical Corporation

LONDON, UK, PHILADELPHIA, MISSISSAUGA, ON, and VANCOUVER, Sept. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) and ID Biomedical Corporation (TSX: IDB; NASDAQ: IDBE) today announced...

GlaxoSmithKline To Acquire ID Biomedical Corporation

Columbia, Sept. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE:GSK) and ID Biomedical Corporation (TSE:IDB)(NASDAQ:IDBE) today announced a definitive agreement for GSK to acquire ID...